Smartphone monitoring, quantitative orbital imaging and clinical data will support a planned longitudinal study and a TORC-led research database.
SEOUL, South Korea, Nov. 17, 2026 /PRNewswire/ -- Thyroscope (THYROSCOPE INC.) and The Orbital Radiology Center (TORC) today announced a memorandum of understanding to investigate an integrated approach to monitoring thyroid eye disease (TED) using smartphone-based artificial intelligence, quantitative orbital imaging and longitudinal clinical data.
Thyroscope will contribute its Glandy smartphone-based AI platform for monitoring patients between clinical visits, while TORC will provide quantitative orbital imaging expertise. Together, the partners will develop a multimodal TED research database integrating smartphone-based assessments, quantitative imaging and longitudinal clinical data. BioSight Innovations, also led by TORC CEO Dr. Shoaib Ugradar, will provide treatment sites, clinical assessments and longitudinal follow-up for the initial study.
TORC has provided contracted imaging assessment services for four clinical trials sponsored by Viridian Therapeutics, Zenas BioPharma, Lassen Therapeutics and Immunovant, and for an Amgen post-marketing study. Its scientific work includes nine published papers on quantitative imaging in TED.
Why Better Monitoring Matters
TED is an autoimmune disease that can cause inflammation, proptosis, eyelid retraction, double vision and, in severe cases, irreversible vision loss. Despite expanding treatments, assessment still relies on scheduled clinic visits. Measurements such as proptosis and the Clinical Activity Score (CAS) may vary between assessors and do not fully capture changes within orbital tissues.
The partners will study whether home measurements and imaging improve longitudinal assessment.
Combining Complementary Technologies
Thyroscope's Glandy TED suite uses smartphone images and patient-reported information to assess inflammatory activity (Glandy CAS), proptosis (Glandy EXO) and eyelid morphology (Glandy LID). Its clinician-facing Glandoc platform makes patient-generated information available for review between appointments. All three Glandy TED solutions have obtained medical device authorization in South Korea and CE marking under the European Medical Device Regulation (EU MDR).
TORC analyzes orbital CT and MRI, clinical photographs and associated clinical data to quantify tissue morphology and volumetric change. Its imaging capabilities complement the more frequent external measurements that patients may collect at home.
BioSight Innovations will provide the clinical infrastructure for treatment and longitudinal follow-up, including conventional pure-tone audiometry using SHOEBOX Audiometry.
Initial 40-Patient Research Study
The partners plan to begin a prospective longitudinal feasibility and validation study of approximately 40 patients receiving TED treatment at BioSight Innovations centers in Los Angeles in January 2027. Participants will be followed from treatment initiation until up to 12 months after treatment completion.
The study will compare smartphone-derived assessments with clinician-performed measurements and examine relationships with quantitative orbital imaging where CT or MRI is clinically appropriate and available. It will explore changes in disease activity, proptosis, eyelid position, anatomical findings, treatment response and clinically confirmed recurrence.
All participants will undergo conventional audiometry at BioSight using SHOEBOX Audiometry. These measurements will inform iterative development and evaluation of an investigational smartphone-based pure-tone hearing assessment integrated into Glandy. The study will assess agreement, distinguishing development from independent validation. The smartphone test is not intended to replace conventional audiometry.
The initial study is designed to establish feasibility and measurement agreement, not to validate recurrence prediction or treatment-selection algorithms. Interim findings are targeted for the first quarter of 2028, depending on enrollment and data availability.
Building a Multimodal TED Research Database
TORC and Thyroscope plan to jointly develop a longitudinal, multimodal TED research database integrating orbital imaging, smartphone-based assessments, standardized clinical findings, treatment exposures, outcomes and audiometric data. Future phases may incorporate consented tissue-derived and molecular information and larger patient cohorts.
The longer-term goal is to support studies of treatment response, disease recurrence, imaging biomarkers and potential predictors of therapeutic benefit.
Subject to scientific validation and appropriate data governance, the resource could also support pharmaceutical research into reproducible clinical trial endpoints and patient stratification.
Leadership Perspectives
DR. SHOAIB UGRADAR
CEO, TORC
"Thyroid eye disease is entering a new era of targeted therapeutics, yet our ability to objectively characterize treatment response and predict recurrence remains limited," said Dr. Shoaib Ugradar, CEO of TORC. "By combining quantitative orbital imaging with measurements collected between visits, we hope to better understand how patients respond, why some relapse and how more personalized care might eventually be supported."
JAEMY PARK
CEO, Thyroscope
"Combining Glandy's smartphone-based assessments with TORC's imaging expertise creates an opportunity to study thyroid eye disease more continuously," said Jaemy Park, CEO of Thyroscope. "We aim to make objective measurement more accessible while contributing patient-generated information to rigorous longitudinal research."
About the Organizations
Thyroscope is a South Korean medical technology company developing AI-based assessment and monitoring technologies for thyroid disorders. Its Glandy TED portfolio includes smartphone-based tools for disease activity, proptosis and eyelid assessment. Learn more at www.thyroscope.com/en.
The Orbital Radiology Center (TORC) is a medical technology company specializing in AI-based quantitative orbital imaging and TED research. It provides contracted imaging assessment services to pharmaceutical development programs and is developing the longitudinal multimodal TED research database. Website: www.torc-research.com
BioSight Innovations provides TED treatment services, standardized clinical assessments and follow-up, including SHOEBOX Audiometry. Website: www.biosightinnovations.com
Research and Regulatory Information
The memorandum of understanding is non-binding, and the study and database remain planned initiatives. Glandy authorizations and certifications vary by product and jurisdiction; authorization outside the United States does not constitute US FDA clearance. Investigational technologies have not been established as substitutes for clinical examination or conventional audiometry.
Study activities and research data use will be subject to applicable approvals, consent and privacy safeguards. The named pharmaceutical companies do not sponsor or endorse this collaboration by virtue of their separate contractual relationships with TORC. Dr. Ugradar leads both TORC and BioSight Innovations.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Thyroscope and TORC Announce Strategic Collaboration to Advance AI-Driven Precision Medicine in Thyroid Eye Disease
Thyroscope and TORC Announce Strategic Collaboration to Advance AI-Driven Precision Medicine in Thyroid Eye Disease
Thyroscope and TORC Announce Strategic Collaboration to Advance AI-Driven Precision Medicine in Thyroid Eye Disease
HONG KONG, Nov. 17, 2026 /PRNewswire/ -- The 2026 HKMA/HKJC Annual Conference was successfully held on 16 November 2026 at the Hong Kong Convention and Exhibition Centre with close to 2,000 participants joining physically and online. The Conference brought together prominent business leaders who shared with participants their invaluable insights under the theme of "Capitalizing on Hong Kong's Strategic Edge in a Changing World". Mr Eddie Yue JP, Chief Executive, Hong Kong Monetary Authority delivered an opening keynote speech while the closing keynote speech was delivered by Mr Anil Wadhwani, Chief Executive Officer, Prudential plc.
In his welcoming address, Prof Winfried Engelbrecht-Bresges GBS JP, Chairperson of The Hong Kong Management Association (HKMA), stated that the overarching theme of the Conference, "Capitalizing on Hong Kong's Strategic Edge in a Changing World," comes at a pivotal moment. He noted that, as Hong Kong actively aligns with the Government's strategic roadmap, anchored in its landmark first Five-Year Plan, the city is accelerating its transformation and sharpening its competitive edge. From strengthening its core role as the "Four Centres" and expanding its high-calibre talent pool, to expediting the Northern Metropolis and deepening Greater Bay Area (GBA) integration, Hong Kong is positioning itself as a vital hub for international collaboration while advancing social well-being and public governance. To that end, he said, the programme of the Conference has been carefully designed so that every session directly reinforces these policy priorities, namely Strategic Growth and Trade, GBA Integration and Healthcare Innovation, The Digital Shift and Legal Innovation, and Education, Talent, and Leadership. Together, he added, these interconnected pillars chart a clear course for Building Hong Kong's Next Chapter of Growth.
Mr Lawrence Lam, Chairperson of the 2026 HKMA/HKJC Annual Conference Organizing Committee and Chief Executive Officer, Prudential Hong Kong Ltd, said in his opening remarks that their theme, "Capitalizing on Hong Kong's Strategic Edge in a Changing World", was absolutely timely. He noted that Hong Kong has always been a place of connections, and that the question today was how they could add even greater value to those connections. He added that they were privileged to host 19 esteemed speakers and panellists, alongside a distinguished audience of senior executives joining them both in person and virtually from across Hong Kong, the region, and around the globe. He further expressed confidence that the conference would prove both deeply inspiring and immensely practical, encouraging all guests to ask bold questions, exchange ideas freely, and build meaningful connections that would drive Hong Kong's continued success.
The Presentation of AMD Professors of Practice was also held at the Conference. The two new Professors of Practice this year are:
- Prof Helen Chan, Co-founder and CEO, Vita Green Health Products Company Limited
- Prof Margaret Cheng JP, Human Resources Director, MTR Corporation Limited
With the concerted efforts of the Conference Organizing Committee under the chairmanship of Mr Lam, the following distinguished speakers were invited to share their wisdom at the conference:
PLENARY SESSION 1: STRATEGIC GROWTH FOR HONG KONG
Session Chairperson:
- Mr Lawrence Lam, Chief Executive Officer, Prudential Hong Kong Ltd and Chairperson, Organizing Committee, HKMA/HKJC Annual Conference 2026
Session Keynote Speaker:
- Mr Eddie Yue JP, Chief Executive, Hong Kong Monetary Authority
PLENARY SESSION 2: HONG KONG AS A SUPER VALUE ADDER FOR GLOBALIZATION IN A MULTIPOLAR WORLD
Session Chairperson:
- Mr Alok Jha, Chief Strategy and Transformation Officer, Prudential Hong Kong Ltd
Session Keynote Speaker:
- Dr Rocky Tung, Executive Director, Financial Services Development Council
Panelists:
- Mrs Angelina Cheung JP, Permanent Secretary for Financial Services and the Treasury (Financial Services), HKSAR Government
- Ms Michelle Kwok, Managing Director & Head of HK Equity Research, HSBC
- Dr Shen Jianguang, VP and Chief Economist, JD Inc
PLENARY SESSION 3: THE DIGITAL SHIFT: ELEVATING BUSINESS WITH TECHNOLOGY
Session Chairperson:
- Mr Jonathan Chiu, President, Schneider Electric Hong Kong and Member, Organizing Committee, HKMA/HKJC Annual Conference 2026
Speakers:
- Mr Brian Sun, Assistant Commissioner (Data Applications), Digital Policy Office
- Mr William Ho, Executive Director, Corporate Development, Airport Authority Hong Kong
- Mr Yan Hao, General Manager of Marketing and Cooperation for Greater Bay Area, ByteDance
PLENARY SESSION 4: FROM CREATION TO PROTECTION: HONG KONG'S CREATIVE ECONOMY AND LEGAL EDGE
Session Chairperson:
- Ms Aveline San, Hong Kong CEO and Banking Head, Citi and Member, Organizing Committee, HKMA/HKJC Annual Conference 2026
Session Keynote Speaker:
- Prof The Hon Nick Chan BBS MH JP, Member of Legal Functional Constituency, Legislative Council, HKSAR; Partner, Squire Patton Boggs
Panelists:
- Ir Prof Sunny Lee BBS JP, Chairman, Steering Committee of the Hong Kong Intellectual Property Academy Pilot Programme
- Ms Rene Yuan, Vice President, CMC Inc.
PLENARY SESSION 5: HEALTHCARE INNOVATION: POWERING HONG KONG'S GROWTH FRONTIER THROUGH GBA INTEGRATION
Session Chairperson:
- Dr Maggie Lo, Chief Manager (Life and Health Technology), Office for Attracting Strategic Enterprises (OASES)
Session Keynote Speaker:
- Mr K K Tong, Chief Executive Officer, New Frontier Health (Hong Kong)
Panelists:
- Ms Ying Shi, Head of Pharmacy, GBA, New Frontier Health (Hong Kong)
- Mr Qiang Lyu, General Manager, AstraZeneca Hong Kong and Macau
- Dr Xin Liu, Vice President, MGI Tech
PLENARY SESSION 6: SHAPING TOMORROW: EDUCATION, TALENT, AND LEADERSHIP FOR A CHANGING WORLD
Session Chairperson:
- Mr Alex Wong, Deputy CEO, Strategy & Marketing, Hong Kong Representative Office, Huawei International Co. Limited and Member, Organizing Committee, HKMA/HKJC Annual Conference 2026
Speakers:
- Prof Frederik Anseel, Dean, HKUST Business School, The Hong Kong University of Science and Technology
- Ms Joy Xu, Group Chief People & Culture Officer, DFI Retail Group
- Ms Jennie Tung, Global Head, Bain Academy
PLENARY SESSION 7: BUILDING HONG KONG'S NEXT CHAPTER OF GROWTH
Session Chairperson:
- Mr Jason Ding, Managing Partner, Greater China, Bain & Company and Member, Organizing Committee, HKMA/HKJC Annual Conference 2026
Closing Keynote Speaker:
- Mr Anil Wadhwani, Chief Executive Officer, Prudential plc
Members of the 2026 Annual Conference Organizing Committee include:
- Mr Lawrence Lam, Chief Executive Officer, Prudential Hong Kong Ltd (Chairperson)
- Mr Jonathan Chiu, President, Schneider Electric Hong Kong
- Mr Oscar Chow, Executive Director and Vice Chairman, Chevalier Group
- Mr Jason Ding, Managing Partner, Greater China, Bain & Company
- Ms Aveline San, Hong Kong CEO and Banking Head, Citi
- Mr Alex Wong, Deputy CEO, Strategy & Marketing, Hong Kong Representative Office, Huawei International Co. Limited
- Mr Carl Wu, Group CEO & Co-founder, New Frontier Group
- Mr Peter Yan JP, Director-General, Office for Attracting Strategic Enterprises (OASES)
| Title Sponsor: - The Hong Kong Jockey Club Lead Sponsor: - Prudential Hong Kong Limited Grand Sponsors: - AIA Group - DALLOYAU - HKT Limited - Huawei International Co. Limited - MTR Corporation - The Hong Kong and China Gas Company Limited - Standard Chartered Bank Premium Sponsors: - Hong Yip Holdings Limited - McDonald's Hong Kong Sponsors: - Bain & Company - CLP Power Hong Kong - Crystal International Group - Sino Group - TAL Apparel Webinar Network Sponsor: - HKT Limited | |
Title Sponsor:
- The Hong Kong Jockey Club
Lead Sponsor:
- Prudential Hong Kong Limited
Grand Sponsors:
- AIA Group
- DALLOYAU
- HKT Limited
- Huawei International Co. Limited
- MTR Corporation
- The Hong Kong and China Gas Company Limited
- Standard Chartered Bank
Premium Sponsors:
- Hong Yip Holdings Limited
- McDonald's Hong Kong
Sponsors:
- Bain & Company
- CLP Power Hong Kong
- Crystal International Group
- Sino Group
- TAL Apparel
Webinar Network Sponsor:
- HKT Limited
Please click here to download more event photos
About The Hong Kong Management Association
The Hong Kong Management Association (HKMA) was established in 1960. As a non-profit making professional organization, its vision is to be the leading professional organization advancing management excellence in Hong Kong and the Region. To nurture human capital through management education and training at all levels, the Association offers over 2,000 training programmes and activities to more than 50,000 participants annually. A diverse range of programmes are provided including Bachelor, Master and Doctoral degrees offered in partnership with prestigious universities worldwide; Diploma programmes; Certificate courses; Distance Learning courses; seminars and workshops; as well as short courses for business executives and professionals. To promote best practices in management, the Association organizes nine annual business awards, which have become the highlights of the business community. The Association also provides around 13,000 members with a platform for the exchange of ideas, networking and personal development.
HKMA Website: www.hkma.org.hk/
HKMA Facebook: www.facebook.com/HKMAfb
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
THE HONG KONG MANAGEMENT ASSOCIATION 2026 HKMA/ HKJC ANNUAL CONFERENCE ON "Capitalizing on Hong Kong's Strategic Edge in a Changing World"